Profil
Jörgen Lönngren is currently a Director at Immuneed AB. Previously, he held Director positions at Gyros AB, LightUp Technologies AB, Oncopeptides AB, and Calliditas Therapeutics AB. He also worked as an Investment Manager at Industrifonden from 2000 to 2010 and as the Head of Pharmacia Biotech AB from 1982 to 1993.
Additionally, he was the President of Professional Genetics Labs AB. Lönngren earned a doctorate degree from the University of Stockholm in 1972.
Postes actifs de Jörgen Lönngren
| Sociétés | Poste | Début |
|---|---|---|
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Develops drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Jörgen Lönngren
| Sociétés | Poste | Fin |
|---|---|---|
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Private Equity Investor | 01/02/2010 |
Pharmacia Biotech AB
Pharmacia Biotech AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | 01/01/1993 |
| ONCOPEPTIDES AB | Directeur/Membre du Conseil | - |
Professional Genetics Labs AB
Professional Genetics Labs AB Miscellaneous Commercial ServicesCommercial Services Provides laboratory research services | President | - |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Directeur/Membre du Conseil | - |
Formation de Jörgen Lönngren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Health Technology |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Finance |
Pharmacia Biotech AB
Pharmacia Biotech AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Professional Genetics Labs AB
Professional Genetics Labs AB Miscellaneous Commercial ServicesCommercial Services Provides laboratory research services | Commercial Services |
LightUp Technologies AB
LightUp Technologies AB Miscellaneous Commercial ServicesCommercial Services Develops and manufactures polymerase chain reaction products | Commercial Services |
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Develops drugs | Health Technology |
















